Hyperbaric oxygen as an adjuvant treatment for patients with COVID- 19 severe hypoxaemia: a randomised controlled trial
19/12/2021
אין תגובות
http://orcid.org/0000-0003-0907-5968David Blusztein1, Diem Dinh2, Dion Stub3,4, Luke Dawson1, Angela Brennan2, Christopher Reid5, Karen Smith6, Ziad Nehme6, http://orcid.org/0000-0002-1579-9279Emily Andrew6, Stephen Bernard2,4, Jeffrey Lefkovits1 Correspondence to Dr David Blusztein, The Royal Melbourne Hospital, Melbourne, Victoria, Australia; davidblusztein@gmail.com Abstract Background Hyperbaric oxygen
